{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:34:56Z","timestamp":1794274496736,"version":"4.9.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Insulin resistance (IR) is a central pathophysiological feature of type 2 diabetes mellitus (T2DM) and is closely associated with chronic low-grade inflammation. Simple systemic inflammatory markers derived from routine laboratory testing may reflect this inflammatory\u2013metabolic state; however, their clinical relevance in relation to IR remains incompletely defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective cross-sectional study, 2,177 patients with T2DM and 327 age- and sex-matched healthy controls were included. Insulin resistance was assessed using the homeostasis model assessment index (HOMA-IR), and patients with T2DM were classified as insulin-resistant or non\u2013insulin-resistant based on established criteria. Systemic inflammatory markers, including the neutrophil-to-lymphocyte ratio (NLR), high-sensitivity C-reactive protein (hs-CRP), and white blood cell count (WBC), were analysed. Associations with IR were examined using correlation analysis and multivariable logistic regression. Receiver operating characteristic (ROC) curve analysis was performed to evaluate discriminative performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Levels of NLR, hs-CRP, and WBC were significantly higher in patients with T2DM than in healthy controls and were further elevated in insulin-resistant patients. All three markers were positively correlated with HOMA-IR, with NLR showing the strongest association (\n                      <jats:italic>r<\/jats:italic>\n                      \u202f=\u202f0.280,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001). In multivariable logistic regression analysis, NLR remained independently associated with insulin resistance after adjustment for body mass index, glycated haemoglobin, and triglyceride levels. ROC analysis demonstrated that NLR had the highest area under the curve (AUC\u202f=\u202f0.670), indicating modest discriminative ability, with higher sensitivity but lower specificity compared with hs-CRP and WBC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Systemic inflammatory markers, particularly NLR, are significantly associated with insulin resistance in patients with T2DM. Although the discriminative performance of NLR was modest, its simplicity, low cost, and availability from routine complete blood counts support its potential role as a complementary marker associated with IR rather than a standalone diagnostic tool. Prospective studies are needed to clarify temporal relationships and validate these findings across diverse populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1737989","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T14:06:20Z","timestamp":1768917980000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Correlation between systemic inflammation markers and insulin resistance in type 2 diabetes mellitus patients and its diagnostic value analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Yongcheng","family":"Jiang","sequence":"first","affiliation":[{"name":"The Second School of Clinical Medicine, Southern Medical University","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiping","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Zhujiang Hospital, Southern Medical University","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Li","sequence":"additional","affiliation":[{"name":"The Second School of Clinical Medicine, Southern Medical University","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Zhu","sequence":"additional","affiliation":[{"name":"The Second School of Clinical Medicine, Southern Medical University","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijing","family":"Liang","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Southern Medical University","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjing","family":"Chen","sequence":"additional","affiliation":[{"name":"The Second School of Clinical Medicine, Southern Medical University","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Deng","sequence":"additional","affiliation":[{"name":"The Second School of Clinical Medicine, Southern Medical University","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"He","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Zhujiang Hospital, Southern Medical University","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01607","article-title":"Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes","volume":"10","author":"Zatterale","year":"2020","journal-title":"Front Physiol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"110817","DOI":"10.1016\/j.pnpbp.2023.110817","article-title":"Inflammation and lipid metabolism as potential biomarkers of memory impairment across type 2 diabetes mellitus and severe mental disorders","volume":"127","author":"S\u00e1nchez-Ort\u00ed","year":"2023","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1038\/s41416-023-02214-0","article-title":"Systemic inflammatory prognostic scores in advanced pancreatic adenocarcinoma","volume":"128","author":"Ma","year":"2023","journal-title":"Br J Cancer"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e39007","DOI":"10.1097\/md.0000000000039007","article-title":"Prognostic value of systemic immune-inflammation index, neutrophil-lymphocyte ratio, and thrombocyte-lymphocyte ratio in critically ill patients with moderate to severe traumatic brain injury","volume":"103","author":"Arslan","year":"2024","journal-title":"Medicine"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2147\/tcrm.s244623","article-title":"Neutrophil\u2013lymphocyte ratio (NLR) for predicting clinical outcomes in patients with coronary artery disease and type 2 diabetes mellitus: a propensity score matching analysis","volume":"16","author":"Qiao","year":"2020","journal-title":"Ther Clin Risk Manag"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.eprac.2021.11.083","article-title":"Is the neutrophil-to-lymphocyte ratio an exceptional Indicator for metabolic syndrome disease and outcomes?","volume":"28","author":"Hashemi Moghanjoughi","year":"2022","journal-title":"Endocr Pract"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1172\/jci200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Invest"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1172\/jci88884","article-title":"Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk","volume":"127","author":"Goldfine","year":"2017","journal-title":"J Clin Invest"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.3390\/ijms23073636","article-title":"Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases","volume":"23","author":"Buonacera","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2007\/95103","article-title":"Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy","volume":"2007","author":"Kern","year":"2007","journal-title":"J Diabetes Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/1753-0407.13250","article-title":"\"the effect of short-term intensive insulin therapy on inflammatory cytokines in patients with newly diagnosed type 2 diabetes,\" journal of","volume":"14","author":"He","year":"2022","journal-title":"Diabetes"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.20945\/2359-3997000000029","article-title":"Short-term insulin intensive therapy decreases MCP-1 and NF-\u03baB expression of peripheral blood monocyte and the serum MCP-1 concentration in newlydiagnosed type 2 diabetics","volume":"62","author":"Lin","year":"2018","journal-title":"Arch Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1210\/jc.2013-3092","article-title":"Toll-like receptor status in obesity and metabolic syndrome: a translational perspective","volume":"99","author":"Jialal","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/nm.2885","article-title":"Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase","volume":"18","author":"Talukdar","year":"2012","journal-title":"Nat Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.4049\/jimmunol.1002615","article-title":"Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes","volume":"186","author":"Jagannathan-Bogdan","year":"2011","journal-title":"J Immunol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.cmet.2018.08.003","article-title":"Insulin receptor-mediated stimulation boosts T cell immunity during inflammation and infection","volume":"28","author":"Tsai","year":"2018","journal-title":"Cell Metab"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"10566","DOI":"10.1038\/s41598-018-28646-w","article-title":"Reference values for white blood-cell-based inflammatory markers in the Rotterdam study: a population-based prospective cohort study","volume":"8","author":"Fest","year":"2018","journal-title":"Sci Rep"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1113\/jp276747","article-title":"Cardiomyopathy in obesity, insulin resistance and diabetes","volume":"598","author":"Nakamura","year":"2019","journal-title":"J Physiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","journal-title":"Nat Rev Immunol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1737989\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:38:36Z","timestamp":1771918716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1737989\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":21,"alternative-id":["10.3389\/fmed.2025.1737989"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1737989","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"article-number":"1737989"}}